Insider Trading activities of Carbylan Therapeutics, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Carbylan Therapeutics, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Carbylan Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Carbylan Therapeutics, Inc. since 2005. The reporting company's ticker symbol is KALV. The reporting company's CIK number is 1348911.
The total value of stock buying since 2005 is $42,266,904.
The total value of stock sales since 2005 is $30,040,759.
The total value of stock option exercises since 2005 is $338,242.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Carbylan Therapeutics, Inc. (KALV).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-10 2,265,065 $19,316,904 2,725,283 $28,659,762 0 $0
2017-09 0 $0 176,647 $1,343,997 0 $0
2016-11 0 $0 0 $0 42,429 $332,642
2015-12 0 $0 10,000 $37,000 10,000 $5,600
2015-04 4,590,000 $22,950,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Carbylan Therapeutics, Inc. insiders (KALV)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-12 Shah Rajeev M. Buy 850,000 8.50 7,225,000
2017-10-12 Novo Holdings A/s (10% Owner) Sale 1,726,481 9.26 15,987,214
2017-10-12 Kolchinsky Peter Buy 850,000 8.50 7,225,000
2017-10-12 Aldrich Richard (Director) Buy 565,065 8.61 4,866,904
2017-10-11 Novo Holdings A/s (10% Owner) Sale 35,519 10.21 362,755
2017-10-10 Novo Holdings A/s (10% Owner) Sale 963,283 12.78 12,309,793
2017-09-15 Novo Holdings A/s (10% Owner) Sale 140,747 7.50 1,055,883
2017-09-14 Novo Holdings A/s (10% Owner) Sale 10,000 8.05 80,500
2017-09-13 Novo Holdings A/s (10% Owner) Sale 25,900 8.02 207,614
2016-11-21 Maroney Marcee (VP, Clinical Affairs) Option Ex 4,664 7.84 36,565
2016-11-21 Renzi David (President & CEO) Option Ex 36,640 7.84 287,257
2016-11-21 Basta Steven L Option Ex 1,125 7.84 8,820
2015-12-30 Renzi David (President & CEO) Sale 10,000 3.70 37,000
2015-12-30 Renzi David (President & CEO) Option Ex 10,000 .56 5,600
2015-04-14 Vivo Ventures Vi Affiilates Fund, L.p. (10% Owner) Buy 1,012,500 5.00 5,062,500
2015-04-14 Cha Albert (Director) Buy 1,012,500 5.00 5,062,500
2015-04-14 Nasr Khaled (10% Owner) Buy 810,000 5.00 4,050,000
2015-04-14 Nohra Guy P (Director) Buy 877,500 5.00 4,387,500
2015-04-14 Janney Daniel (10% Owner) Buy 877,500 5.00 4,387,500

Insider trading activities including stock purchases, stock sales, and option exercises of KALV listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Carbylan Therapeutics, Inc. (symbol KALV, CIK number 1348911) see the Securities and Exchange Commission (SEC) website.